Section 3719.07 | Record of all controlled substances received, administered, dispensed, or used.
(A) As used in this section, "description" means the dosage form, strength, and quantity, and the brand name, if any, or the generic name, of a drug or controlled substance.
(B)(1) Every licensed health professional authorized to prescribe drugs shall keep a record of all controlled substances received and a record of all controlled substances administered, dispensed, or used other than by prescription. Every other person, except a pharmacist, manufacturer, or wholesaler, who is authorized to purchase and use controlled substances shall keep a record of all controlled substances purchased and used other than by prescription. The records shall be kept in accordance with division (C)(1) of this section.
(2) Manufacturers and wholesalers shall keep records of all controlled substances compounded, mixed, cultivated, grown, or by any other process produced or prepared by them, and of all controlled substances received or sold by them. The records shall be kept in accordance with division (C)(2) of this section.
(3) Every category III terminal distributor of dangerous drugs shall keep records of all controlled substances received or sold. The records shall be kept in accordance with division (C)(3) of this section.
(4) Every person who sells or purchases for resale schedule V controlled substances exempted by section 3719.15 of the Revised Code shall keep a record showing the quantities and kinds thereof received or sold. The records shall be kept in accordance with divisions (C)(1), (2), and (3) of this section.
(C)(1) The records required by divisions (B)(1) and (4) of this section shall contain the following:
(a) The description of all controlled substances received, the name and address of the person from whom received, and the date of receipt;
(b) The description of controlled substances administered, dispensed, purchased, sold, or used; the date of administering, dispensing, purchasing, selling, or using; the name and address of the person to whom, or for whose use, or the owner and species of the animal for which the controlled substance was administered, dispensed, purchased, sold, or used.
(2) The records required by divisions (B)(2) and (4) of this section shall contain the following:
(a) The description of all controlled substances produced or prepared, the name and address of the person from whom received, and the date of receipt;
(b) The description of controlled substances sold, the name and address of each person to whom a controlled substance is sold, the amount of the controlled substance sold to each person, and the date it was sold.
(3) The records required by divisions (B)(3) and (4) of this section shall contain the following:
(a) The description of controlled substances received, the name and address of the person from whom controlled substances are received, and the date of receipt;
(b) The name and place of residence of each person to whom controlled substances, including those otherwise exempted by section 3719.15 of the Revised Code, are sold, the description of the controlled substances sold to each person, and the date the controlled substances are sold to each person.
(D) Every record required by this section shall be kept for a period of t hre e years.
The keeping of a record required by or under the federal drug abuse control laws, containing substantially the same information as specified in this section, constitutes compliance with this section.
Every person who purchases for resale or who sells controlled substance preparations exempted by section 3719.15 of the Revised Code shall keep the record required by or under the federal drug abuse control laws.
Available Versions of this Section
- July 22, 1998 – Senate Bill 66 - 122nd General Assembly [ View July 22, 1998 Version ]
- August 31, 2016 – House Bill 116 - 131st General Assembly [ View August 31, 2016 Version ]
- September 29, 2017 – Amended by House Bill 49 - 132nd General Assembly [ View September 29, 2017 Version ]
- March 22, 2019 – Amended by Senate Bill 229 - 132nd General Assembly [ View March 22, 2019 Version ]